ReShape Lifesciences Investor Relations Material
Latest events
Q4 2024
ReShape Lifesciences
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from ReShape Lifesciences Inc
Access all reports
ReShape Lifesciences Inc. is a medical device company specializing in weight-loss solutions and metabolic health treatments. The company’s product portfolio includes minimally invasive devices designed to assist in weight management, such as intragastric balloon systems and laparoscopic medical implants. ReShape also provides support programs and digital tools to aid patients and healthcare providers in managing obesity and related health conditions. The company is headquartered in San Clemente, California, and its shares are listed on the NASDAQ Stock Exchange.
Latest articles
)
MSCI: Indexing the World
The story of how MSCI has become the backbone of global finance through its indexes, powering decision-making across trillions in assets.
30 May 2025
)
A Purpose-Built AI Chat for Finance and IR Professionals
Quartr Pro's new AI chat lets IR and finance professionals ask anything across 13,000+ public companies and get instant answers.
27 May 2025
)
Costco Wholesale: The Model of Scalable Simplicity
Costco's rise from warehouse club to retail giant is built on low prices, scale efficiency, and a model designed for lasting customer value.
26 May 2025
Ticker symbol
RSLS
Country
🇺🇸 United States